CeO2-Azacrown Conjugate as a Nanoplatform for Combined Radiopharmaceuticals.
Nanomaterials (Basel)
; 12(24)2022 Dec 18.
Article
em En
| MEDLINE
| ID: mdl-36558337
This study is one of the first attempts to assess CeO2 nanoparticles as a nanoplatform for radiopharmaceuticals with radionuclides. The process of functionalization using a bifunctional azacrown ligand is described, and the resulting conjugates are characterized by IR and Raman spectroscopy. Their complexes with 207Bi show a high stability in medically relevant media, thus encouraging the further study of these conjugates in vivo as potential combined radiopharmaceuticals.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article